Logo image
Multifocal atrophic gastritis and gastric carcinoma (Reprinted from Gastroenterology Clinics of North America, vol 31, pg 499, 2002)
Journal article

Multifocal atrophic gastritis and gastric carcinoma (Reprinted from Gastroenterology Clinics of North America, vol 31, pg 499, 2002)

E I Faraji and B B Frank
Hematology/oncology clinics of North America, v 17(2), pp 487-504
01 Apr 2003

Abstract

Hematology Life Sciences & Biomedicine Oncology Science & Technology
Gastric carcinoma is a worldwide disease with widely variable incidence in different geographic areas. In contrast to an overall reduction in incidence in the United States and other industrialized countries, gastric cancer remains the second most common cancer in the world. It continues to be a serious problem in developing countries, and even within specific groups within the United States. In these high-risk populations, multifocal atrophic gastritis (MAG) appears to be the precursor lesion. This article discusses appropriate screening and preventive measures and the identification of co-factors that might interact with H pylori infection to increase gastric cancer risk. To make an impact on gastric cancer incidence and mortality, serious consideration should be given to early H pylori eradication in high-risk groups, and endoscopic surveillance according to the updated Sydney system in some patients; dysplastic lesions should be removed without delay. Studies currently in progress may tell us whether H pylori eradication can prevent later development of gastric carcinoma and thus eliminate a major cause of mortality worldwide.

Metrics

11 Record Views

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Hematology
Oncology
Logo image